The Effect of Narrowband UV-B Treatment for Psoriasis on Vitamin D Status During Wintertime in Ireland | Dermatology | JAMA Dermatology | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 18.206.177.17. Please contact the publisher to request reinstatement.
1.
Griffiths  CEBarker  JN Pathogenesis and clinical features of psoriasis.  Lancet 2007;370 (9583) 263- 271PubMedGoogle ScholarCrossref
2.
Ibbotson  SHBilsland  DCox  NH  et al. British Association of Dermatologists, An update and guidance on narrowband ultraviolet B phototherapy: a British Photodermatology Group Workshop report.  Br J Dermatol 2004;151 (2) 283- 297PubMedGoogle ScholarCrossref
3.
Parrish  JAJaenicke  KF Action spectrum for phototherapy of psoriasis.  J Invest Dermatol 1981;76 (5) 359- 362PubMedGoogle ScholarCrossref
4.
Guilhou  JJColette  CMonpoint  SLancrenon  EGuillot  BMonnier  L Vitamin D metabolism in psoriasis before and after phototherapy.  Acta Derm Venereol 1990;70 (4) 351- 354PubMedGoogle Scholar
5.
Osmancevic  ALandin-Wilhelmsen  KLarko  O  et al.  UVB therapy increases 25(OH) vitamin D syntheses in postmenopausal women with psoriasis.  Photodermatol Photoimmunol Photomed 2007;23 (5) 172- 178PubMedGoogle ScholarCrossref
6.
Osmancevic  ALandin-Wilhelmsen  KLarko  OWennberg  AMKrogstad  AL Vitamin D production in psoriasis patients increases less with narrowband than with broadband ultraviolet B phototherapy.  Photodermatol Photoimmunol Photomed 2009;25 (3) 119- 123PubMedGoogle ScholarCrossref
7.
Czarnecki  D Narrowband ultraviolet B therapy is an effective means of raising serum vitamin D levels.  Clin Exp Dermatol 2008;33 (2) 202PubMedGoogle ScholarCrossref
8.
Heaney  RPDavies  KMChen  TCHolick  MFBarger-Lux  MJ Human serum 25-hydroxycholocalciferol response to extended oral dosing with cholecalciferol.  Am J Clin Nutr 2003;77 (1) 204- 210PubMedGoogle Scholar
9.
Reichrath  J Vitamin D and the skin: an ancient friend, revisited.  Exp Dermatol 2007;16 (7) 618- 625PubMedGoogle ScholarCrossref
10.
Lehmann  BGenehr  TKnuschke  PPietzsch  JMeurer  M UVB-induced conversion of 7-dehydrocholesterol to 1 alpha,25-dihydroxyvitamin D3 in an in vitro human skin equivalent model.  J Invest Dermatol 2001;117 (5) 1179- 1185PubMedGoogle ScholarCrossref
11.
McKenna  MJ Differences of vitamin D status between countries in young adults and the elderly.  Am J Med 1992;93 (1) 69- 77PubMedGoogle ScholarCrossref
12.
Armas  LAGDowell  SAkhter  M  et al.  Ultraviolet-B radiation increases serum 25-hydroxyvitamin D levels: the effect of UVB dose and skin colour.  J Am Acad Dermatol 2007;57 (4) 588- 593PubMedGoogle ScholarCrossref
13.
Bikle  DAdams  JChristakos  S Vitamin D: production, metabolism, mechanism of action, and clinical requirements. Rosen  C Primer on Metabolic Bone Diseases and Disorders of Mineral Metabolism. Washington, DC American Society for Bone and Mineral Research2008;141- 149Google Scholar
14.
Singh  SAiba  SManome  HTagami  H The effects of dexamethasone, cyclosporine, and vitamin D3 on the activation of dendritic cells stimulated by haptens.  Arch Dermatol Res 1999;291 (10) 548- 554PubMedGoogle ScholarCrossref
15.
Griffin  MDLutz  WPhan  VABachman  LAMcKean  DJKumar  R Dendritic cell modulation by 1 alpha,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo.  Proc Natl Acad Sci U S A 2001;98 (12) 6800- 6805PubMedGoogle ScholarCrossref
16.
Adorini  LPenna  GGiarratana  NUskokovic  M Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting allograft rejection and autoimmune diseases.  J Cell Biochem 2003;88 (2) 227- 233PubMedGoogle ScholarCrossref
17.
Griffin  MDDong  XKumar  R Vitamin D receptor-mediated suppression of RelB in antigen presenting cells: a paradigm for ligand-augmented negative transcriptional regulation.  Arch Biochem Biophys 2007;460 (2) 218- 226PubMedGoogle ScholarCrossref
18.
Reichrath  JRappl  G Ultraviolet light (UV)-induced immunosuppression: is vitamin D the missing link?  J Cell Biochem 2003;89 (1) 6- 8PubMedGoogle ScholarCrossref
19.
Webb  ARKline  LHolick  MF Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 in human skin.  J Clin Endocrinol Metab 1988;67 (2) 373- 378PubMedGoogle ScholarCrossref
20.
Dawson-Hughes  BHeaney  RPHolick  MFLips  PMeunier  PJVieth  R Estimates of optimal vitamin D status.  Osteoporos Int 2005;16 (7) 713- 716PubMedGoogle ScholarCrossref
21.
Holick  MF Vitamin D deficiency.  N Engl J Med 2007;357 (3) 266- 281PubMedGoogle ScholarCrossref
22.
Markham  TRogers  SCollins  P Narrowband UV-B (TL-O1) phototherapy vs oral 8-methoxypsoralen psoralen UVA for treatment of chronic plaque psoriasis.  Arch Dermatol 2003;139 (3) 325- 328PubMedGoogle ScholarCrossref
23.
 British National Formulary Web site. http://bnf.org/bnf/bnf/59/5760.htm. Accessed October 26, 2009
24.
Morimoto  SYoshikawa  K Psoriasis and vitamin D3: a review of our experience.  Arch Dermatol 1989;125 (2) 231- 234PubMedGoogle ScholarCrossref
25.
Staberg  BOxholm  AKlemp  PChristiansen  C Abnormal vitamin D metabolism in patients with psoriasis.  Acta Derm Venereol 1987;67 (1) 65- 68PubMedGoogle Scholar
26.
Dawe  RS A quantitative review of studies comparing the efficacy of narrow-band and broad-band ultraviolet B for psoriasis.  Br J Dermatol 2003;149 (3) 669- 672PubMedGoogle ScholarCrossref
27.
McKenna  MJFreaney  RMeade  AMuldowney  FP Hypovitaminosis D and elevated serum alkaline phosphatase in elderly Irish people.  Am J Clin Nutr 1985;41 (1) 101- 109PubMedGoogle Scholar
28.
Hill  TRMcCarthy  DJakobsen  JLamberg-Allardt  CKiely  MCashman  KD Seasonal changes in vitamin D status and bone turnover in healthy Irish postmenopausal women.  Int J Vitam Nutr Res 2007;77 (5) 320- 325PubMedGoogle ScholarCrossref
29.
Moan  JLagunova  ZLindberg  FAPorojnicu  AC Seasonal variation of 1,25-dihydroxyvitamin D and its association with body mass index and age.  J Steroid Biochem Mol Biol 2009;113 (3-5) 217- 221PubMedGoogle ScholarCrossref
30.
Holick  MF MrOs is D-ficient.  J Clin Endocrinol Metab 2009;94 (4) 1092- 1093PubMedGoogle ScholarCrossref
31.
McKenna  MJFreaney  R Secondary hyperparathyroidism in the elderly: means to defining hypovitaminosis D.  Osteoporos Int 1998;8 ((suppl 2)) S3- S6PubMedGoogle ScholarCrossref
32.
McKenna  MJFreaney  RByrne  P  et al.  Safety and efficacy of increasing wintertime vitamin D and calcium intake by milk fortification.  QJM 1995;88 (12) 895- 898PubMedGoogle Scholar
33.
Cashman  KDHill  TRLucey  AJ  et al.  Estimation of the dietary requirement for vitamin D in healthy adults.  Am J Clin Nutr 2008;88 (6) 1535- 1542PubMedGoogle ScholarCrossref
34.
Kuchuk  NOPluijm  SMvan Schoor  NMLooman  CWSmit  JHLips  P Relationships of serum 25-hydroxyvitamin D to bone mineral density and serum parathyroid hormone and markers of bone turnover in older persons.  J Clin Endocrinol Metab 2009;94 (4) 1244- 1250PubMedGoogle ScholarCrossref
Study
August 16, 2010

The Effect of Narrowband UV-B Treatment for Psoriasis on Vitamin D Status During Wintertime in Ireland

Author Affiliations

Author Affiliations: Departments of Dermatology (Drs Ryan, Moran, Collins, Rogers, and Kirby) and Endocrinology (Dr McKenna), and Metabolism Laboratory (Drs Murray and Brady), St Vincent's University Hospital, Dublin, Ireland. Dr Ryan is now with Baylor Research Institute, Dallas, Texas.

Arch Dermatol. 2010;146(8):836-842. doi:10.1001/archdermatol.2010.195
Abstract

Objectives  To determine whether narrowband UV-B (NB–UV-B) may mediate its beneficial effect on psoriasis by increasing vitamin D levels, and to assess the effect of NB–UV-B on vitamin D status in patients with psoriasis in wintertime.

Design  A prospective controlled study from October 2008 to February 2009.

Setting  A dermatology outpatient department at a university teaching hospital.

Patients  Thirty consecutive patients with psoriasis treated with NB–UV-B and 30 control patients with psoriasis were recruited. Control patients were recruited within 1 week of treated patients to control for seasonal variation of serum 25-hydroxyvitamin D [25(OH)D] levels. One patient with photoaggravated psoriasis was withdrawn from the study.

Intervention  Narrowband UV-B was administered 3 times per week.

Main Outcome Measure  Serum 25(OH)D was measured at baseline, after 4 weeks and at completion of treatment.

Results  Levels of serum 25(OH)D increased significantly (P < .001) from a median (range) of 23 (9-46) ng/mL at baseline to 59 (32-112) ng/mL at the end of NB–UV-B treatment compared with no change in the control group. The change in serum 25(OH)D level correlated with the number of exposures of NB–UV-B (r = 0.61; P < .001) and cumulative UV-B dose (r = 0.47; P = .01) but not with treatment response. At the end of the study, all patients in the treatment group were vitamin D sufficient, but 75% of the control group had vitamin D insufficiency [serum 25(OH)D level <20 ng/mL]. In a multiple regression model, prior phototherapy was the sole predictor of baseline serum 25(OH)D level (r2 = 0.13; P = .006), whereas the number of exposures of NB–UV-B predicted change in serum 25(OH)D level (r2 = 0.38; P = .001).

Conclusions  Narrowband UV-B effectively increases serum 25(OH)D level while clearing psoriasis. Up to 75% of Irish patients with psoriasis were shown to be vitamin D insufficient during wintertime.

×